Brief: 89bio Q4 Net Income USD -118.354 Million Vs. IBES Estimate USD -84.1 Million
27/02/2025 21:05
Feb 27 (Reuters) - 89bio Q4 operating expenses USD 122.005 million. Q4 basic EPS USD -1.02 Q4 pretax profit USD -118.097 million vs. IBES estimate USD -88.2 million Q4 operating income USD -122.005 million vs. IBES estimate USD -86.2 million